Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Not to open a can of worms but....TOMMEEK

TOM,

I should have clarified a little better. I think it's grand that RG consulted more than just one shareholder. The more the better, I agree with you. I suppose what is odd to me is, one would think that a new CEO would consult the company's Advisory Board's Shareholder Representative to get feedback. After all, it should be a recognized role, shouldn't it?

I suppose that if I were the CEO, I would have included Brian if I were conducting feedback queries, especially if I were including other(random) shareholders. I'm sure that these shareholders were not random in the sense of just anyone but more likely they were shareholders of influence or great insight.

It's just odd to me that there is no mention of the shareholders' representative as being consulted. That does not mean that Brian was not included. All I'm saying is that RG's message excludes any mention of it, lending 'us' to question it, especially with Brian's recent show of frustration on the Agoar Board.

Of course, this is all IMO.

Regards,
PxP

Share
New Message
Please login to post a reply